Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Trabeculectomy for Glaucoma
NCT01122966Phase 3Unknown
- Sponsor
- Samsung Medical Center
- Start
- Mar 2010
- Primary completion
- Mar 2011
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in Glaucoma, sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT01122966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01122966.